Log In
BCIQ
Print this Print this
 

CB102

  Manage Alerts
Collapse Summary General Information
Company Cantabio Pharmaceuticals Inc.
DescriptionDJ-1 targeting small molecule
Molecular Target DJ-1 (PARK7)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today